Company intelligence / Profile preview

Tilray

New York City, New York, United Statestilray.com ↗

Ownership: Public · TLRY
Employees: ~330
Development stage: Commercial

Overview

Tilray has established itself as a global leader in medical cannabis with commercial operations across North America and Europe. The company was the first to conduct a Health Canada-approved clinical trial for medical cannabis in Canada and remains the leading provider of medical cannabis extracts in Germany. It continues to expand its portfolio with new high-potency formulations and premium flower genetics for patients requiring advanced cannabinoid therapies. Recent launches include German-grown GMP-certified flowers under new cultivation licenses.

Therapeutic areas: OncologyPsychiatryNeurology
Modalities: Plant-derived therapy (medical cannabis flower and extracts)Small molecule (cannabinoids THC and CBD are small molecules)Biologic (for some GMP-certified products derived from plant material)
Industry: Biotech

Drug pipeline

8 assets

Tilray FS Oral Solution

7 more assets in the full pipeline.

Request access →

Partnerships

Sandoz/Novartis subsidiary for co-branded non-smokeable/non-combustible products globallydistribution partnerships across Europe

Financials

Market cap: $480.9M
Total revenue: $281.7M
Enterprise value: $648M

Beyond the preview

Go deeper on Tilray.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tilray.

Explore the full profile